High Note Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.9M Buy
3,250
+74
+2% +$75.6K 0.67% 36
2026
Q1
$2.92M Buy
3,176
+3
+0.1% +$3.04K 0.57% 40
2025
Q4
$3.41M Buy
3,173
+22
+0.7% +$21K 0.67% 40
2025
Q3
$2.4M Sell
3,151
-33
-1% -$24.6K 0.48% 47
2025
Q2
$2.48M Buy
3,184
+14
+0.4% +$10.9K 0.57% 40
2025
Q1
$2.62M Sell
3,170
-24
-0.8% -$20K 0.65% 35
2024
Q4
$2.47M Buy
3,194
+6
+0.2% +$4.97K 0.64% 35
2024
Q3
$2.82M Sell
3,188
-24
-0.7% -$21.6K 0.81% 31
2024
Q2
$2.91M Buy
3,212
+2
+0.1% +$1.6K 0.89% 30
2024
Q1
$2.5M Sell
3,210
-777
-19% -$553K 0.81% 32
2023
Q4
$2.32M Sell
3,987
-34
-0.8% -$19.8K 0.87% 34
2023
Q3
$2.16M Buy
4,021
+181
+5% +$93.3K 0.89% 34
2023
Q2
$1.8M Sell
3,840
-297
-7% -$125K 0.73% 38
2023
Q1
$1.42M Buy
4,137
+101
+3% +$34.1K 0.59% 41
2022
Q4
$1.48M Buy
4,036
+15
+0.4% +$5.32K 0.62% 41
2022
Q3
$1.43M Buy
4,021
+148
+4% +$46.9K 0.57% 42
2022
Q2
$1.26M Buy
3,873
+430
+12% +$129K 0.49% 49
2022
Q1
$985K Buy
+3,443
New +$886K 0.35% 52

Other funds holding LLY

High Note Wealth's LLY Position: Q2 2026 in Review

High Note Wealth increased its Eli Lilly (LLY) stake by 2.3% in Q2 2026, buying an estimated $75.6K and bringing the position to 3,250 shares worth $3.9M. The position accounts for 0.67% of the portfolio, ranked #36.

High Note Wealth first reported a position in LLY in Q1 2022 and has held it in 18 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • High Note Wealth held 3,250 shares of Eli Lilly worth $3.9M as of Q2 2026.
  • High Note Wealth bought 74 Eli Lilly shares in Q2 2026, an estimated $75.6K.
  • Eli Lilly made up 0.67% of High Note Wealth's portfolio in Q2 2026, its #36 holding.
  • High Note Wealth first reported a position in Eli Lilly in Q1 2022 and has held it in 18 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on High Note Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.